Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Bayesian estimates of the incidence of rare cancers in Europe.

Botta L, Capocaccia R, Trama A, Herrmann C, Salmerón D, De Angelis R, Mallone S, Bidoli E, Marcos-Gragera R, Dudek-Godeau D, Gatta G, Cleries R; RARECAREnet Working group.

Cancer Epidemiol. 2018 Jun;54:95-100. doi: 10.1016/j.canep.2018.04.003. Epub 2018 Apr 21.

PMID:
29684802
2.

Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.

Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A; RARECAREnet Working Group.

Eur J Surg Oncol. 2018 Feb 14. pii: S0748-7983(18)30416-5. doi: 10.1016/j.ejso.2018.02.006. [Epub ahead of print]

PMID:
29526370
3.

Treatment challenges in and outside a network setting: Head and neck cancers.

Orlandi E, Alfieri S, Simon C, Trama A, Licitra L; RARECAREnet Working Group.

Eur J Surg Oncol. 2018 Feb 14. pii: S0748-7983(18)30417-7. doi: 10.1016/j.ejso.2018.02.007. [Epub ahead of print]

PMID:
29478741
4.

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.

Imbimbo M, Maury JM, Garassino M, Girard N; RARECAREnet Working Group.

Eur J Surg Oncol. 2018 Feb 2. pii: S0748-7983(18)30114-8. doi: 10.1016/j.ejso.2018.01.078. [Epub ahead of print]

PMID:
29426781
5.

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.

Lykoudis PM, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai GK; RARECARENet Working Group.

Eur J Surg Oncol. 2017 Oct 16. pii: S0748-7983(17)30941-1. doi: 10.1016/j.ejso.2017.08.019. [Epub ahead of print]

PMID:
29126671
6.

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.

Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group.

Eur J Surg Oncol. 2017 Nov 3. pii: S0748-7983(17)30947-2. doi: 10.1016/j.ejso.2017.09.025. [Epub ahead of print]

PMID:
29108961
7.

Epidemiology of rare cancers and inequalities in oncologic outcomes.

Gatta G, Trama A, Capocaccia R; RARECARENet Working Group.

Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30685-6. doi: 10.1016/j.ejso.2017.08.018. [Epub ahead of print]

PMID:
29032924
8.

Treatment challenges in and outside a network setting: Soft tissue sarcomas.

Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet Working Group.

Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30705-9. doi: 10.1016/j.ejso.2017.09.015. [Epub ahead of print]

PMID:
28985973
9.

Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study.

Minicozzi P, Innos K, Sánchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, Botta L, Visser O, Rossi S, Tavilla A, Sant M; EUROCARE-5 Working Group.

Eur J Cancer. 2017 Oct;84:335-353. doi: 10.1016/j.ejca.2017.07.015. Epub 2017 Sep 1.

PMID:
28865261
10.

Geographical variability in survival of European children with central nervous system tumours.

Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sánchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L; EUROCARE-5 Working Group.

Eur J Cancer. 2017 Sep;82:137-148. doi: 10.1016/j.ejca.2017.05.028. Epub 2017 Jul 6.

PMID:
28689091
11.

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.

Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A; RARECAREnet working group.

Lancet Oncol. 2017 Aug;18(8):1022-1039. doi: 10.1016/S1470-2045(17)30445-X. Epub 2017 Jul 4. Erratum in: Lancet Oncol. 2017 Aug;18(8):e433.

PMID:
28687376
12.

Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.

Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group.

Eur J Cancer. 2017 May;77:140-152. doi: 10.1016/j.ejca.2017.02.023. Epub 2017 Apr 11.

PMID:
28410490
13.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

14.

Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).

Mounier M, Bossard N, Remontet L, Belot A, Minicozzi P, De Angelis R, Capocaccia R, Iwaz J, Monnereau A, Troussard X, Sant M, Maynadié M, Giorgi R; EUROCARE-5 Working Group; CENSUR Working Survival Group.

Lancet Haematol. 2015 Nov;2(11):e481-91. doi: 10.1016/S2352-3026(15)00155-6. Epub 2015 Oct 23.

PMID:
26686258
15.

Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.

De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2254-2268. doi: 10.1016/j.ejca.2015.08.003. Epub 2015 Sep 26.

PMID:
26421827
16.

Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study.

Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, Knijn A, Pastorino U, Salmerón D, Trama A, Sant M; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2242-2253. doi: 10.1016/j.ejca.2015.07.033. Epub 2015 Sep 26.

PMID:
26421826
17.

Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study.

Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2231-2241. doi: 10.1016/j.ejca.2015.07.032. Epub 2015 Sep 26.

PMID:
26421825
18.

Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5.

Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, Sant M; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2217-2230. doi: 10.1016/j.ejca.2015.07.028. Epub 2015 Sep 26.

PMID:
26421824
19.

Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study.

Trama A, Foschi R, Larrañaga N, Sant M, Fuentes-Raspall R, Serraino D, Tavilla A, Van Eycken L, Nicolai N; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2206-2216. doi: 10.1016/j.ejca.2015.07.027. Epub 2015 Sep 26.

PMID:
26421823
20.

Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study.

Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larrañaga N, Rossi S, Siesling S, Minicozzi P; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2191-2205. doi: 10.1016/j.ejca.2015.07.022. Epub 2015 Sep 26.

PMID:
26421822

Supplemental Content

Loading ...
Support Center